Recombinant Human Tie-2 Fc Chimera, CF

• Supplier: R&D Systems
• Catalog: 313-TI-100
• Category: Protein
• Nature: Recombinant
• Source: Mouse myeloma cell line, NS0-derived
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• SwissProt/Accession: Q02763
• Gene: TEK

Product References

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial - Angiopoietins assemble distinct Tie2 signalling complexes in endothelial

Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, Olsen BR, Alitalo K. Nat Cell Biol. 2008 May;10(5):527-37.

Proangiogenic effects of protease-activated receptor 2 are tumor necrosis - Proangiogenic effects of protease-activated receptor 2 are tumor necrosis

Zhu T, Sennlaub F, Beauchamp MH, Fan L, Joyal JS, Checchin D, Nim S, Lachapelle P, Sirinyan M, Hou X, Bossolasco M, Rivard GE, Heveker N, Chemtob S. Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):744-50. Epub 2006 Jan 26.

Wnt5a signaling induces proliferation and survival of endothelial cells in vitro - Wnt5a signaling induces proliferation and survival of endothelial cells in vitro

Masckauchan TN, Agalliu D, Vorontchikhina M, Ahn A, Parmalee NL, Li CM, Khoo A, Tycko B, Brown AM, Kitajewski J. Mol Biol Cell. 2006 Dec;17(12):5163-72. Epub 2006 Oct 11.

Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in - Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in

Red-Horse K, Rivera J, Schanz A, Zhou Y, Winn V, Kapidzic M, Maltepe E, Okazaki K, Kochman R, Vo KC, Giudice L, Erlebacher A, McCune JM, Stoddart CA, Fisher SJ. J Clin Invest. 2006 Oct;116(10):2643-52. Epub 2006 Sep 21.

Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody. - Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.

Popkov M, Jendreyko N, McGavern DB, Rader C, Barbas CF 3rd. Cancer Res. 2005 Feb 1;65(3):972-81.

Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular - Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular

Satchell SC, Anderson KL, Mathieson PW. J Am Soc Nephrol. 2004 Mar;15(3):566-74.

Suppression of angiogenesis and tumor growth by selective inhibition of - Suppression of angiogenesis and tumor growth by selective inhibition of

Oliner J, Min H, Leal J, Yu D, Rao S, You E, Tang X, Kim H, Meyer S, Han SJ, Hawkins N, Rosenfeld R, Davy E, Graham K, Jacobsen F, Stevenson S, Ho J, Chen Q, Hartmann T, Michaels M, Kelley M, Li L, Sitney K, Martin F, Sun JR, Zhang N, Lu J, Estrada J, Kumar R, Coxon A, Kaufman S, Pretorius J, Scully S, Cattley R, Payton M, Coats S, Nguyen L, Desilva B, Ndifor A, Hayward I, Radinsky R, Boone T, Kendall R. Cancer Cell. 2004 Nov;6(5):507-16.

Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a - Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a

Caine GJ, Blann AD, Stonelake PS, Ryan P, Lip GY. Eur J Clin Invest. 2003 Oct;33(10):883-90.